Kudo C - Search Results

1

BRAF point mutations in primary melanoma show different prevalences by subtype.

Sasaki Y, Niu C, Makino R, Kudo C, Sun C, Watanabe H, Matsunaga J, Takahashi K, Tagami H, Aiba S, Horii A. Sasaki Y, et al. Among authors: kudo c. J Invest Dermatol. 2004 Jul;123(1):177-83. doi: 10.1111/j.0022-202X.2004.22722.x. J Invest Dermatol. 2004. PMID: 15191558 Free article.

2

Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo.

Kudo C, Yamakoshi H, Sato A, Nanjo H, Ohori H, Ishioka C, Iwabuchi Y, Shibata H. Kudo C, et al. BMC Pharmacol. 2011 May 28;11:4. doi: 10.1186/1471-2210-11-4. BMC Pharmacol. 2011. PMID: 21619659 Free PMC article.

3

Structure-activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof.

Yamakoshi H, Ohori H, Kudo C, Sato A, Kanoh N, Ishioka C, Shibata H, Iwabuchi Y. Yamakoshi H, et al. Among authors: kudo c. Bioorg Med Chem. 2010 Feb;18(3):1083-92. doi: 10.1016/j.bmc.2009.12.045. Epub 2009 Dec 23. Bioorg Med Chem. 2010. PMID: 20060305

4

Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo.

Shibata H, Yamakoshi H, Sato A, Ohori H, Kakudo Y, Kudo C, Takahashi Y, Watanabe M, Takano H, Ishioka C, Noda T, Iwabuchi Y. Shibata H, et al. Among authors: kudo c. Cancer Sci. 2009 May;100(5):956-60. doi: 10.1111/j.1349-7006.2009.01127.x. Cancer Sci. 2009. PMID: 19445025 Free article.

5

Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis.

Sato A, Kudo C, Yamakoshi H, Uehara Y, Ohori H, Ishioka C, Iwabuchi Y, Shibata H. Sato A, et al. Among authors: kudo c. Cancer Sci. 2011 May;102(5):1045-51. doi: 10.1111/j.1349-7006.2011.01886.x. Epub 2011 Feb 24. Cancer Sci. 2011. PMID: 21272158 Free article.

6

Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma.

Kudo C, Yamakoshi H, Sato A, Ohori H, Ishioka C, Iwabuchi Y, Shibata H. Kudo C, et al. Anticancer Res. 2011 Nov;31(11):3719-26. Anticancer Res. 2011. PMID: 22110192

7

KSRP/FUBP2 Is a Binding Protein of GO-Y086, a Cytotoxic Curcumin Analogue.

Yamakoshi H, Kanoh N, Kudo C, Sato A, Ueda K, Muroi M, Kon S, Satake M, Ohori H, Ishioka C, Oshima Y, Osada H, Chiba N, Shibata H, Iwabuchi Y. Yamakoshi H, et al. Among authors: kudo c. ACS Med Chem Lett. 2010 Jun 4;1(6):273-6. doi: 10.1021/ml1000454. eCollection 2010 Sep 9. ACS Med Chem Lett. 2010. PMID: 24900207 Free PMC article.

8

Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia.

Soga Y, Yamasuji Y, Kudo C, Matsuura-Yoshimoto K, Yamabe K, Sugiura Y, Maeda Y, Ishimaru F, Tanimoto M, Nishimura F, Takashiba S. Soga Y, et al. Among authors: kudo c. Support Care Cancer. 2009 May;17(5):581-7. doi: 10.1007/s00520-008-0532-z. Epub 2008 Nov 18. Support Care Cancer. 2009. PMID: 19015893 Free article.

9

Periodontal disease as part of the insulin resistance syndrome in diabetic patients.

Nishimura F, Soga Y, Iwamoto Y, Kudo C, Murayama Y. Nishimura F, et al. Among authors: kudo c. J Int Acad Periodontol. 2005 Jan;7(1):16-20. J Int Acad Periodontol. 2005. PMID: 15736891

10

Appearance of multidrug-resistant opportunistic bacteria on the gingiva during leukemia treatment.

Soga Y, Saito T, Nishimura F, Ishimaru F, Mineshiba J, Mineshiba F, Takaya H, Sato H, Kudo C, Kokeguchi S, Fujii N, Tanimoto M, Takashiba S. Soga Y, et al. Among authors: kudo c. J Periodontol. 2008 Jan;79(1):181-6. doi: 10.1902/jop.2008.070205. J Periodontol. 2008. PMID: 18166109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page